Does Medicare Cover GLP-1 Weight-Loss Drugs? Medicare GLP-1 Bridge FAQs

GLP-1 medications have become an important topic for people managing weight and related health conditions. Medicare coverage can be confusing because coverage depends on the medication’s use, the beneficiary’s health status, and the type of Medicare drug coverage they have.

Starting July 1, 2026, some eligible beneficiaries may access certain GLP-1 weight-loss medications through the temporary Medicare GLP-1 Bridge program.

Does Medicare cover GLP-1 drugs for weight loss?

Medicare now provides access to certain GLP-1 weight-loss drugs for eligible people through the Medicare GLP-1 Bridge. This temporary CMS program runs through December 31, 2027.

It does not mean every GLP-1 medication is covered for every person or every condition. Eligibility and prior authorization requirements apply.

Do I need Medicare Part D?

Yes. To use the Medicare GLP-1 Bridge, you need qualifying Medicare drug coverage, such as:

• A standalone Medicare Part D prescription drug plan
• A Medicare Advantage plan that includes drug coverage
• Certain Special Needs Plans
• Certain employer or union group waiver plans

People with some other types of Medicare coverage may not qualify. If you are unsure what type of drug coverage you have, contact Medicare or your plan.

What is the monthly cost?

For people approved for the Medicare GLP-1 Bridge, the cost is $50 for a one-month supply of an eligible medication.

This amount does not count toward your regular Part D deductible or annual out-of-pocket maximum because the Bridge program operates outside the standard Part D benefit.

Why might someone with diabetes not qualify for the Bridge program?

The Bridge program is designed for certain people seeking GLP-1 medications for weight management who are not already eligible to receive a GLP-1 drug through their Part D coverage.

If you have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease, your Part D plan may cover a GLP-1 medication based on that diagnosis. Your provider and drug plan can help you understand the appropriate coverage route.

Does Medicare require prior authorization for GLP-1 drugs?

A provider may need to complete prior authorization for the Medicare GLP-1 Bridge. Your provider must send the prescription to the pharmacy and, when required, submit the necessary authorization information.

Your provider must also certify that the medication is being used as part of a lifestyle program focused on diet and exercise.

What should I do if I think I qualify?

Take these three steps:

1. Review your Medicare drug coverage and confirm that you have Part D.
2. Talk with your doctor or other qualified health care provider about whether a GLP-1 medication is medically appropriate.
3. Ask your provider and pharmacy about the prescription and prior-authorization process.

Do not stop, start, or change a prescription medication based on online information alone.

Can an insurance agent help?

A licensed agent may help you understand the difference between Medicare Advantage, Part D, and Medicare Supplement coverage and review your plan options during an eligible enrollment period. However, only your health care provider can determine whether a GLP-1 medication is clinically appropriate, and Medicare or the applicable program determines eligibility.

For official eligibility details, use the Medicare GLP-1 Bridge page or call 1-800-MEDICARE.

Important Medicare GLP-1 Bridge facts to remember

• The program is temporary: July 1, 2026, through December 31, 2027.
• It is available nationwide to eligible beneficiaries.
• It covers only specific medications and dosage forms.
• Eligibility depends on Medicare drug coverage, BMI, and qualifying health criteria.
• Approval is not guaranteed.
• The program’s $50 copayment does not count toward Part D out-of-pocket spending.

This article is educational and not medical advice, a plan recommendation, an enrollment solicitation, or a guarantee of benefits or coverage. Medicare program rules, formularies, and eligibility requirements may change. Speak with your health care provider about treatment decisions and contact Medicare for official coverage information.